Skip to content
value.today

Vascular Pathways Inc

Total raised
$19 M
2 rounds on record
Latest round
$6 M
May 2014
First round on record
Oct 2010
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Vascular Pathways Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2014$6 MNo. 2$2 to $10 million

Vascular Pathways Inc: Raise no. 2, May 2014

Investors in this round

6 investors had bought by the notice of May 14, 2014: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $11 M offered; $6 M still to sell
Smallest investment taken
$1
What was sold
equity, debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • William Bold · Executive Officer, Director
  • Alan Weinstein · Director
  • Amir Belson · Director
  • Bosun Hau · Director
  • Matthew Hermann · Director
  • Myles Greenberg · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Ilan Lovinsky, Secretary. Source: SEC Form D, newest notice filed May 14, 2014. Read the notice at the SEC.

equity, debt, optionsSEC
Oct 2010$14 MNo. 1$10 to $50 million

Vascular Pathways Inc: Raise no. 1, Oct 2010

Investors in this round

9 investors had bought by the notice of May 8, 2012: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$14 M of $14 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Amir T. Belson · Executive Officer, Director
  • Eugene T. Starr · Executive Officer, Director
  • Alan T. Weinstein · Director
  • Myles T. Greenberg · Director
  • Stephen T. Reeders · Director
  • Walter T. Lin · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Total Offering Amount $13,875,220.00 Total Amount Sold $13,875,220.00”

Signed by Eugene T. Starr, President and CEO. Source: SEC Form D and 1 amendment, newest notice filed May 8, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Vascular Pathways Inc chose not to state its revenue in its newest notice of a funding round (May 2014).

    SEC Form D · May 2014

  • The industry group it chose in its notices: Other.

    SEC Form D · May 2014

That is all the official record says: Vascular Pathways Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Vascular Pathways Inc is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 9 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Vascular Pathways Inc
NameRoleNamed in
William BoldExecutive officerMay 2014
Amir T. BelsonExecutive officerMay 2012
Eugene T. StarrExecutive officerMay 2012
Alan WeinsteinDirectorMay 2014
Amir BelsonDirectorMay 2014
Bosun HauDirectorMay 2014
Matthew HermannDirectorMay 2014
Myles GreenbergDirectorMay 2014
William BoldDirectorMay 2014
Alan T. WeinsteinDirectorMay 2012
Amir T. BelsonDirectorMay 2012
Eugene T. StarrDirectorMay 2012
Myles T. GreenbergDirectorMay 2012
Stephen T. ReedersDirectorMay 2012
Walter T. LinDirectorMay 2012